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Complex chromosomal rearrangements (CCRs) are
structural abnormalities involving at least three
breakpoints on two or more chromosomes with
exchanges of chromosomal segments. The great
majority of CCRs are combinations of transloca-
tions and are rare events, either familial or de novo.
The number of breakpoints may vary from the
simplest, with 3 breakpoints, to the most complex,
with ≥8 breakpoints. The risk of abnormalities in-
creases with the number of breaks.
According to the literature, about 70 % of CCRs are
detected in phenotypically normal subjects, 20–25 %
in patients with congenital abnormalities and/or men-
tal retardation and 5–10 % in foetuses undergoing
prenatal diagnosis. The majority of CCRs (70–75 %)
are de novo; these are found in equal proportion be-
tween phenotypically normal (49 %) and abnormal
subjects (51 %), due to submicroscopic imbalances
or other genetic defects. These de novo CCRs appear
to be preferentially of paternal origin.
The authors present the case of a 5-year-old boy
with the clinical indication of developmental delay and
a karyotype showing a complex apparently balanced
translocation involving chromosomes 5, 6 and 15.
High-resolution GTL banding, FISH and arrayCGH
techniques were performed. Conventional and FISH
analysis revealed the presence of 45 chromosomes, with
only one free chromosome 15, and confirmed the com-
plexity of the rearrangement demonstrating that the
derivative of chromosome 6 is composed of 3 distinct
segments derived from chromosomes 5, 6 and 15 with a
deletion of the subtelomeric region of the short arm of
chromosome 5. ArrayCGH technique detected a dele-
tion of the segment 5p15.33-5p15.32, which includes
the subtelomeric region, and another deletion in 15q11.2
that had not been observed by FISH.
The authors emphasize the importance of the com-
bination of high-resolution GTL banding, FISH and
arrayCGH studies in CCRs in order to clarify possible
imbalances and thus allow better genetic counselling
to patients and families.
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Microdeletion 22q11.2 syndrome is one of the most
frequent genomic disorders. The current state-of-art
diagnostic procedure comprises karyotype and FISH
testing with probes targeting the 22q11.2 locus. Due to
its wide phenotypic spectrum, variable expression and
highly diverse clinical features overlapping with other
clinical entities, significant number of patients present-
ing clinical features of microdeletion 22q11.2 fail to
reach diagnosis at standard cytogenetic testing. Here,
we have performed further characterization of their
genomic disorders using aCGH technique.
Twenty-six children fulfilling Tobias criteria but
negative at standard cytogenetic evaluation of
22q11.2 were analyzed using whole-genome aCGH
at 20 kb resolution (NimbleGen,Roche). The results
were validated using specific qPCRs.
aCGH allowed for definite diagnosis in five (19 %)
patients. A cryptic chromosomal unbalanced translo-
cation involving the distal fragments of chromosomes
4p and 11q was detected in two siblings, one case had
a well-known 1.9 Mb deletion at 1p36 and one patient
had a novel pathogenic 2.7 Mb deletion at 6p25. In
addition, five patients had interstitial duplications of
average size 0.6 Mb, eventually classified as CNVs.
The results of our study shows that definite diag-
nosis using aCGH may be reached in a minor portion
of the patients only, which undermines its clinical
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